Merck & Co., Inc. (NYSE:MRK) is included among the 10 Best Bear Market Stocks to Invest in Right Now.
On April 22, Merck & Co., Inc. (NYSE:MRK) and Google Cloud announced a major partnership aimed at strengthening Merck’s digital backbone as an AI-enabled enterprise. The multi-year investment, valued at up to $1 billion, will introduce an agentic platform across research and development, manufacturing, commercial, and corporate functions. It also includes Google Cloud engineers working directly with Merck teams to deploy advanced AI tools, including Gemini Enterprise.
The partnership brings together Merck’s scientific and data capabilities with Google Cloud’s AI and cloud platforms. The goal is to digitize data and improve productivity across the company’s global workforce of 75,000 employees, supporting its focus on improving and saving lives. By combining their expertise, the two companies plan to build advanced AI solutions using Google Cloud technology. The effort is expected to support scientific innovation and improve operational performance.
Merck & Co., Inc. (NYSE:MRK) is a global healthcare company that provides health solutions through prescription medicines, including biologic therapies, vaccines, and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products.
While we acknowledge the potential of MRK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 10 Monthly Dividend Stocks To Buy and 10 Best US Stocks to Invest In for Long Term
Disclosure: None. Follow Insider Monkey on Google News.
